KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Non-cash Items: 2012-2024

Historic Non-cash Items for Dynavax Technologies (DVAX) over the last 11 years, with Jun 2024 value amounting to $8.1 million.

  • Dynavax Technologies' Non-cash Items fell 74.19% to $8.1 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.1 million, marking a year-over-year decrease of 74.19%. This contributed to the annual value of $37.4 million for FY2023, which is 129.50% up from last year.
  • Per Dynavax Technologies' latest filing, its Non-cash Items stood at $8.1 million for Q2 2024, which was up 6.08% from $7.7 million recorded in Q1 2024.
  • Over the past 5 years, Dynavax Technologies' Non-cash Items peaked at $42.8 million during Q4 2021, and registered a low of $6,000 during Q1 2020.
  • Over the past 3 years, Dynavax Technologies' median Non-cash Items value was $13.6 million (recorded in 2022), while the average stood at $17.3 million.
  • In the last 5 years, Dynavax Technologies' Non-cash Items slumped by 99.84% in 2020 and then surged by 99,350.00% in 2021.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Non-cash Items stood at $5.6 million in 2020, then spiked by 670.24% to $42.8 million in 2021, then plummeted by 61.90% to $16.3 million in 2022, then surged by 129.50% to $37.4 million in 2023, then slumped by 74.19% to $8.1 million in 2024.
  • Its Non-cash Items was $8.1 million in Q2 2024, compared to $7.7 million in Q1 2024 and $37.4 million in Q4 2023.